drug

A643 (nicotine)

as of 2026-07-01
Add to landscapeMonitor thisCompare thisAsk about this
at a glance
OTHER
Pre-approval / investigational in the US
Developed by Janssen, L.P. - Investigator Initiated Studies Program
2 trials in the graph
Synthesized from structured facts only — each point cited above.

Mechanism & identity

Modality
OTHER

Indications

Trials

2
The Effect of Nicotine on Arousal, Cognition and Social Cognition in Young and Elderly Healthy Subjects.
NCT01181934Early Phase 1Completed
The Effect of Nicotine on Arousal, Cognition and Social Cognition in Schizophrenic Patients
NCT01186471Early Phase 1Completed

Facts & assertions

0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
Janssen, L.P. - Investigator Initiated Studies Program
company
trial
The Effect of Nicotine on Arousal, Cognition and Social Cognition in Young and Elderly Healthy Subjects.
EARLY_PHASE1
trial
The Effect of Nicotine on Arousal, Cognition and Social Cognition in Schizophrenic Patients
EARLY_PHASE1
trial
indication
Schizophrenia
indication
Schizophrenia
indication
Cognition Disorders
indication
Cognition Disorders
indication